SGLT1/2 INHIBITOR LIK066 FOR TREATING OBESITY
- 专利权人:
- Novartis AG
- 发明人:
- Deborah Lynn Keefe,Qing SHAO
- 申请号：
- US16490554
- 公开号：
- US20200121639A1
- 申请日:
- 2018.03.02
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention is drawn to methods for effecting weight loss, e.g.. in the treatment of obesity and related conditions, including conditions associated with and/or caused by obesity per se.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Dosing regimen for SGLT1 / 2 inhibitors
- שיטה להורדת האדמת פנים הקשורה לשימוש שיטתי במעכבי פוספודיאסטראז מטיפוס 5
- ACTIVATED BLOOD COAGULATION FACTOR X (FXA) INHIBITOR
- Targeting of Histone Deacetylase 2, Protein Kinase CK2, and Nuclear Factor NRF2 For Treatment of Inflammatory Diseases
- ACTIVATED BLOOD COAGULATION FACTOR X (FXA) INHIBITOR
